Immune-mediated neuropathy with anti-disialosyl IgM antibodies in diffuse large B-cell lymphoma: A case report and literature review

Gen Shihashi, Takuya Yagi, Shigeaki Suzuki, Morinobu Seki, Sumiko Kohashi, Tomoki Ueda, Kaori Kameyama, Susumu Kusunoki, Hideaki Nakajima, Shinichiro Okamoto, Norihiro Suzuki

Research output: Contribution to journalArticle

2 Citations (Scopus)


A 36-year-old man with diffuse large B-cell lymphoma presented with polyneuropathy, and the diagnostic work-up revealed the presence of IgM antibodies against gangliosides with disialosyl residues (GD1b, GD3). He was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and received high-dose intravenous immunoglobulin for the treatment of neuropathy. After initiating the treatments, the patient's neurological impairment improved dramatically. He currently remains in complete remission without a flare-up of the polyneuropathy. Based upon our experience and other case reports of lymphoma with immune-mediated neuropathy caused by anti-disialosyl ganglioside IgM antibodies, we conclude that determining the anti-ganglioside antibody profile and beginning early treatment should be considered promptly for patients with malignant lymphoma who develop polyneuropathy.

Original languageEnglish
Pages (from-to)1647-1651
Number of pages5
JournalInternal Medicine
Issue number13
Publication statusPublished - 2015 Jul 1



  • Anti-ganglioside antibody
  • Diffuse large B-cell lymphoma
  • Guillain-Barré syndrome
  • Immune-mediated neuropathy
  • Malignant lymphoma
  • Paraneoplastic syndrome

ASJC Scopus subject areas

  • Internal Medicine

Cite this